What is Crystal Structure Prediction (CSP)?
Crystal Structure Prediction (CSP) refers to the ability to identify the correct crystal structure(s) that will form from a given molecule, based on its molecular structure. Most methods use informatics and computational science techniques. The field first gained popularity in the 1980s, following statements from John Maddox on how chemists still struggle to predict crystal formation.
"One of the continuing scandals in the physical sciences is that it remains in general impossible to predict the structure of even the simplest crystalline solids from a knowledge of their chemical composition." Maddox, J. Crystals from first principles. Nature 335, 201 (1988). Maddox – a chemist and physicist by training – served as an editor for Nature for 22 years.
Typically, a CSP analysis starts with a 2D structure of a molecule. From that, CSP researchers build a 3D molecular model, and then use advanced search techniques to generate plausible based on free energy and packing density. . A landscape is a scatterplot of potential that graphs free energy and density. Often the more plausible – and therefore more likely observed – structures have low energy and high density, which is why a scatterplot can prove so helpful in identifying which potential crystal structures warrant additional experimental .
Why is CSP so hard?
- CSP can be expensive – a single landscape can cost between $10,000 and $100,000, and some analyses can take two to three weeks, while others can take two to three months.
- Computational limitations – standard force-fields – and even fast quantum mechanical methods – are not always good enough to rank polymorphs. Researchers must make customized force fields for each family of problems and subsequent energy rankings to make useful predictions.
Polymorph Case Study: ROY (QAXMEH33)
Polymorphs present a unique challenge to CSP researchers. Consider the seemingly simple molecule 5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile – often just called "ROY" (QAXMEH33). ROY stands for "Red Orange Yellow" because the compound varies in color based on the conformational polymorph present. (The molecule's planarity in a given crystal determines the color. There are currently 13 characterized ROY polymorphs, and researchers continue to find new ones. To move forward, we likely need a deeper understanding of the crystallization process as a whole. As Sally Price discusses in the paper "Control and prediction of the organic solid state: a challenge to theory and experiment," we need to move from just structural prediction to predicting structural creation, Read more about it here: Proc. R. Soc. A. 474(2217), 1471-2946 (2018).
What does CSP provide?
A CSP landscape has several applications, including:
- Risk avoidance – discovering more stable structures while establishing manufacturing processes can be costly. Computational models help identify potentially stable polymorphs ahead of time to help limit such risks.
- Manufacturing improvements – computational methods might uncover structures more conducive to manufacturing processes, and they can help determine if an observed crystal is likely to be a highly stable form.
- Patent breaking/protection – discovering crystals with better formulation or different solvation properties can cause companies to lose their patents. Companies can use CSP to look proactively for such polymorphs – to both protect their patents or to break other companies' patents.
- New materials discovery – CSP can help researchers identify specific, potentially stable compounds with desirable qualities that they can then try to synthesize in the lab.
Risk Avoidance Case Study: Ritonavir (YIGPIO)
Ritonavir is an HIV antiviral and a famous example of issues caused by unexpected polymorphs. A late-occurring, more thermodynamically stable polymorph appeared during the scale-up process for manufacturing ritonavir. Once the more stable polymorph appeared, it proved difficult to produce the original therapeutic version. It's estimated to have cost $250 million in lost revenues, and it isn't an isolated case. Several additional examples have occurred since, which you can read about here: Bauer, J., Spanton, S., Henry, R. et al. Ritonavir: An Extraordinary Example of Conformational Polymorphism. Pharm Res 18, 859–866 (2001). Further studies have suggested that even existing drugs may face similar challenges. Marcus A. Neumann and Jacco van de Streek used CSP to analyze this, and they found that between 15 and 45 percent of small-molecule therapeutics are distributed using a seemingly metastable form.
"Based on a thorough and critical analysis of the commercial crystal structure prediction studies of 41 pharmaceutical compounds, we conclude that for between 15 and 45% of all small-molecule drugs currently on the market the most stable experimentally observed polymorph is not the thermodynamically most stable crystal structure and that the appearance of the latter is kinetically Faraday Discuss., 2018,211, 441-458
CSP can help identify these types of issues before manufacturing process are put in place. Consider the (toy) landscapes below.
Imagine that the experimentally observed forms of your crystal are in red, while all other computationally predicted crystal forms are in gray. If your observed forms appear in the landscape on the right, then you can feel more confident that your structures are lower energy and potentially more stable. But if your observed forms appear in a landscape like the one on the left, you know additional lab research might uncover more thermodynamically stable polymorphs.
Research by Pulido and co-workers used CSP techniques and energy-structure-function (ESF) maps to search for structures with high degrees of void space that might produce compounds with applications in gas absorption. Like a CSP landscape, an ESF map graphs predicted crystal structures according to density and energy. However, it also represents a third, physicochemical property using color – in this case, predicted gas storage. Pulido, A., Chen, L., Kaczorowski, T. et al. Functional materials discovery using energy–structure–function maps. Nature 543, 657–664 (2017).
The team produced CSP solid-form landscapes of a series of molecules and then projected the value of properties important for gas storage onto the CSP landscape. Properties like channel dimensionality of the void space and calculated methane capacity could then be viewed alongside packing and energy. This allowed the team to observe low-density structures that still appeared energetically stable that they could attempt to synthesize in the lab. This is how ESF maps guide material design and development.
Experimentalists successfully synthesized the predicted crystal structures of a triptycene molecule (T2) and were able to observe the low-density structures in the lab. Here's an example: DEBXIT01.
The team also investigated designing molecular crystals with even higher porosity levels with a CSP solid-form landscape of a hypothetical, extended T2 form, called T2E. They successfully predicted an ultra-low-density solid T2E molecule: SEMFAU. SEMFAU is an iso-structural of the T2 form with a predicted density of just 0.303 gcm−3 and hexagonal pore channels with diameters of 2.83 nm. The team successfully synthesized it in the lab – further demonstrating how exploration of the solid form landscape of organic molecular crystals via CSP combined with physicochemical projections (ESF map) can inform functional materials design.
Where is CSP headed?
Ideally, in the next 30 years, we'll be able to take a very elaborate molecule and then quickly predict all its solid forms – including salts, solvates and useful conformers – without false positives on a small computational resource. We will then derive calculated information about the predicted structures, such as how to reliably make each form in the lab. We've still quite a way to go.
How is the CCDC advancing CSP?
CCDC is dedicated to advancing structural science, and we sit in a unique position as a charity, as a place of active research and bring together academic intuitions, pharma companies, other software providers and chemical data standards organizations with the common goal of advancing CSP.
The CSP Blind Test
For the past 30 years we've held a blind test aimed at CSP developers in industry and academia with the goal of testing new CSP methods and demonstrating to the broader scientific community the usefulness of CSP. E
- We canvas collaborators to provide experimentally analyzed molecules that are not in the public domain.
- We release the structure with some experimental conditions.
- We give participants one year to submit their predictions using their best CSP methods.
- Once the submissions are in, we review the experimental results and compare to the predictions.
- We review the outcomes and then publish the findings.
The event always generates lots of discussion, learnings and method improvements while giving the participants the opportunity to test and validate their techniques against real data. There are usually participants from pharma and academia that use a variety of different approaches. In the last blind test, there were five systems of differing complexity. We received 25 submissions from 52 academic groups worldwide. Each compound was predicted by at least one of the groups, and the successful approaches highlighted the importance of re-ranking using density functional theory (DFT).
The current blind test started in . The molecules this time display greater complexity than years past, and we'll be releasing more experimental data for some of the systems over the course of the year to simulate how learn more about their systems as time passes. We'll ask participants to account for the new information in their predictions.
Visit our website to learn more about the CCDC's current CSP Blind Test.
Learn more about how to use CSD-Theory to manage CSP data here.
To watch my CSP presentation, visit the Community Initiatives section of our website.